Amelioration of inflammation through reduction of oxidative stress in rheumatoid arthritis by treating fibroblast-like synoviocytes (FLS) with DMF-loaded PLGA nanoparticles
-
Published:2024-03
Issue:
Volume:129
Page:111617
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Royaei MohammadrezaORCID,
Tahoori Mohammad Taher,
Bardania Hassan,
Shams Ali,
Dehghan Ali
Reference38 articles.
1. HLA class II and rheumatoid arthritis: the bumpy road of revelation;Kampstra;Immunogenetics,2017
2. Paul Ehrlich's magic bullet concept: 100 years of progress;Strebhardt;Nat. Rev. Cancer,2008
3. The relationship between physical function, knowledge of disease, social support and self-care behavior in patients with rheumatoid arthritis;Chen;J. Nurs. Res.,2007
4. D. Prosperi, M. Colombo, I. Zanoni, F. Granucci, editors, Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases. Seminars in immunology, Elsevier, 2017.
5. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α–mediated pathway in rheumatoid arthritis;Wang;Arthritis Rheum.,2012